Clinical Trial Update: A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial in adult Chinese subjects with stable plaque psoriasis compared LEO 90100 to Daivobet ointment to evaluate efficacy and safety; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Daivobet Ointment (calcipotriol/betamethasone dipropionate)
• LEO 90100

Snippet

Sponsor: LEO Pharma | Conditions: Stable Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2025-03-21